GLP Watchdog

Allara Health vs Hims

Hims has an open FDA warning letter dated September 9, 2025. Allara Health has none. Allara Health prices medication from $149 a month plus a required membership, so it has no all-in monthly price to set against another seller's. Hims starts at $149 a month (medication only, membership extra) for brand-name semaglutide pill.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Allara Health / Hims

Allara Health logo

Allara Health

6.5/10

Hims logo

Hims

6.7/10

FDA warning letters
None on record
Pharmacy
Brand-name only; no compounding
Lowest standing price
$149/moMedication only; a membership is required on top
$149/moBrand-name semaglutide pill, medication only, membership extra
States
44 states
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit Allara Health
Visit Hims

Neither Allara Health nor Hims pays us. Links to them earn nothing. Scores: Allara Health 6.5, Hims 6.7. How we are paid

What the record shows

  1. 01

    Hims has an open FDA warning letter dated September 9, 2025. Allara Health has none.

  2. 02

    Allara Health prices medication from $149 a month plus a required membership, so it has no all-in monthly price to set against another seller's. Hims starts at $149 a month (medication only, membership extra) for brand-name semaglutide pill.

  3. 03

    Only Hims lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  4. 04

    Hims covers six states Allara Health does not.

  5. 05

    Allara Health does not state its cancellation terms; Hims states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Allara Health

Hims

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Clinician visits, coaching
Medication
Billed separately
Medication
Clinician visits, coaching
Cancel any time
Not stated
Yes, stated
Minimum term
1 month
Monthly membership, auto-renews
Refunds
Refund requests within 30 days of a charge; Allara Rx prescriptions are final sale
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
Early-exit fee
None stated
None stated

Read off each seller’s own pages. Allara Health: September 28, 2026. Hims: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Allara Health

6.5/10
  • No FDA warning letter on record
  • Publishes no GLP-1 price
Visit Allara Health

The case for Hims

6.7/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Allara Health does not price
  • Lists 50 states against 44
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

Scores

Allara Health 6.5 · Hims 6.7 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

9.0A
vs
B
10.0

User Experience15%

7.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.0

Accessibility10%

9.0A
vs
B
10.0

Support10%

4.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Allara Health vs Hims: questions

Hims has an open FDA warning letter dated September 9, 2025. Allara Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Allara Health does not state its cancellation terms. Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed.
Neither Allara Health nor Hims pays us. Links to them earn nothing. Scores: Allara Health 6.5, Hims 6.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks